Related Experiment Videos

Dietary pectin influences fibrin network structure in hypercholesterolaemic subjects

F J Veldman1, C H Nair, H H Vorster

  • 1Department of Paramedical Sciences, Technikon Free State, Bloemfontein, South Africa.

Insights

Dietary pectin supplementation improved cardiovascular health by lowering cholesterol and making fibrin networks less prone to atherosclerosis. This dietary intervention shows therapeutic potential for reducing cardiovascular disease risk.

Area of Science:

  • Cardiovascular Science
  • Nutritional Science
  • Hematology

Background:

  • Fibrinogen and fibrin network quality are risk factors for atherosclerosis, stroke, and cardiovascular heart disease (CHD).
  • Western diets high in fat and sucrose contribute to CHD, while dietary fiber, like pectin, may offer protection.
  • Pectin is known to reduce serum cholesterol levels and evidence suggests fiber intake may positively impact clotting factors.

Purpose of the Study:

  • To investigate the effects of pectin supplementation on fibrinogen levels and fibrin network architecture in hyperlipidaemic individuals.
  • To determine if pectin can alter fibrin network structure independently of changes in plasma fibrinogen concentration.

Main Methods:

  • A randomized controlled trial involving two groups of 10 male hyperlipidaemic volunteers.
  • Participants received either 15 g/day of pectin or a placebo for 4 weeks.
  • Measurements included serum lipid profiles, apolipoproteins, lipoprotein (a), and fibrin network structure variables at baseline and study end.

Main Results:

  • Pectin supplementation significantly reduced total cholesterol, LDL cholesterol, apolipoprotein A & B, and lipoprotein (a).
  • Significant alterations in fibrin network characteristics were observed, with pectin-supplemented individuals showing more permeable networks with lower tensile strength.
  • These modified fibrin networks are considered less atherogenic.

Conclusions:

  • Pectin supplementation positively impacts cardiovascular risk factors by improving lipid profiles and favorably modifying fibrin network architecture.
  • Pectin may exert its beneficial effects through metabolic changes and by influencing fibrin conversion, leading to less atherogenic fibrin structures.
  • Alterations in fibrin network structure can occur independently of changes in plasma fibrinogen levels, highlighting a novel therapeutic target.

Related Concept Videos